Masimo (NASDAQ:MASI) PT Lowered to $130.00

Masimo (NASDAQ:MASIGet Rating) had its price target decreased by stock analysts at Piper Sandler from $160.00 to $130.00 in a report issued on Wednesday, The Fly reports. Piper Sandler’s target price points to a potential upside of 10.20% from the company’s current price.

A number of other equities research analysts have also recently commented on MASI. TheStreet cut shares of Masimo from a “b-” rating to a “c+” rating in a research note on Tuesday, February 22nd. UBS Group dropped their price target on shares of Masimo from $325.00 to $295.00 and set a “buy” rating on the stock in a research note on Wednesday, February 16th. Needham & Company LLC raised shares of Masimo from a “hold” rating to a “buy” rating and set a $205.00 price target on the stock in a research note on Friday, February 18th. Stifel Nicolaus dropped their price target on shares of Masimo from $250.00 to $175.00 and set a “buy” rating on the stock in a research note on Thursday, March 31st. Finally, Wolfe Research initiated coverage on shares of Masimo in a research note on Tuesday, April 5th. They issued a “market perform” rating and a $160.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $210.50.

MASI opened at $117.97 on Wednesday. The firm has a market capitalization of $6.55 billion, a PE ratio of 29.64 and a beta of 1.00. Masimo has a 12-month low of $112.07 and a 12-month high of $305.21. The firm has a 50 day moving average of $142.63 and a two-hundred day moving average of $218.85.

Masimo (NASDAQ:MASIGet Rating) last issued its quarterly earnings data on Tuesday, May 3rd. The medical equipment provider reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.03. The business had revenue of $304.24 million for the quarter, compared to analysts’ expectations of $308.04 million. Masimo had a net margin of 18.53% and a return on equity of 16.06%. The business’s revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company earned $0.90 EPS. As a group, equities research analysts anticipate that Masimo will post 4.29 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Assenagon Asset Management S.A. raised its holdings in Masimo by 1,864.5% in the 1st quarter. Assenagon Asset Management S.A. now owns 535,812 shares of the medical equipment provider’s stock valued at $77,982,000 after buying an additional 508,537 shares during the period. Norges Bank purchased a new stake in Masimo in the 4th quarter valued at about $123,962,000. Wellington Management Group LLP raised its holdings in Masimo by 80.5% in the 3rd quarter. Wellington Management Group LLP now owns 613,664 shares of the medical equipment provider’s stock valued at $166,125,000 after buying an additional 273,728 shares during the period. Invesco Ltd. raised its holdings in Masimo by 12.9% in the 4th quarter. Invesco Ltd. now owns 1,307,606 shares of the medical equipment provider’s stock valued at $382,840,000 after buying an additional 149,083 shares during the period. Finally, Martin Currie Ltd. raised its holdings in Masimo by 28.1% in the 3rd quarter. Martin Currie Ltd. now owns 622,270 shares of the medical equipment provider’s stock valued at $168,455,000 after buying an additional 136,676 shares during the period. Institutional investors and hedge funds own 92.03% of the company’s stock.

About Masimo (Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also

The Fly logo

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.